
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $318.4M | $428.6M | $576.3M | $692.9M | $780.6M | |
Revenue Growth (YoY) | 24.94% | 34.61% | 34.48% | 20.23% | 12.66% | |
Cost of Revenues | $145.5M | $170.6M | $211.9M | $295.4M | $314.7M | |
Gross Profit | $172.8M | $258M | $364.4M | $397.5M | $465.9M | |
Gross Profit Margin | 54.29% | 60.19% | 63.23% | 57.37% | 59.69% | |
R&D Expenses | $75M | $115.7M | $143.9M | $136.9M | $142.5M | |
Selling, General & Admin | $113.7M | $153.5M | $246.2M | $227.8M | $232.4M | |
Other Inc / (Exp) | -$13.3M | -$3.4M | -$407K | -$20.9M | -- | |
Operating Expenses | $188.6M | $269.2M | $390.1M | $364.7M | $374.9M | |
Operating Income | -$15.8M | -$11.2M | -$25.7M | $32.8M | $91M | |
Net Interest Expenses | $13.6M | $3.6M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$42.7M | -$18.2M | -$23.9M | $26.8M | $97.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $911K | $1.3M | $3.9M | $7.4M | $13.2M | |
Net Income to Company | -$43.6M | -$19.5M | -$27.8M | $19.4M | $84.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$43.6M | -$19.5M | -$27.8M | $19.4M | $84.5M | |
Basic EPS (Cont. Ops) | -$0.41 | -$0.21 | -$0.28 | $0.22 | $0.92 | |
Diluted EPS (Cont. Ops) | -$0.41 | -$0.21 | -$0.28 | $0.20 | $0.89 | |
Weighted Average Basic Share | $105.3M | $93.2M | $100.8M | $90.1M | $91.6M | |
Weighted Average Diluted Share | $105.3M | $93.2M | $100.8M | $96.4M | $94.5M | |
EBITDA | $46.5M | $73.9M | $86.7M | $153.6M | $236.9M | |
EBIT | -$29M | -$14.5M | -$15.5M | $35.7M | $106.8M | |
Revenue (Reported) | $318.4M | $428.6M | $576.3M | $692.9M | $780.6M | |
Operating Income (Reported) | -$15.8M | -$11.2M | -$25.7M | $32.8M | $91M | |
Operating Income (Adjusted) | -$29M | -$14.5M | -$15.5M | $35.7M | $106.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $93.7M | $127.3M | $165.1M | $184.7M | $210.7M | |
Revenue Growth (YoY) | 28.67% | 35.95% | 29.69% | 11.87% | 14.06% | |
Cost of Revenues | $39.5M | $47.2M | $71.9M | $75.6M | $81.3M | |
Gross Profit | $54.1M | $80.1M | $93.3M | $109.1M | $129.4M | |
Gross Profit Margin | 57.78% | 62.93% | 56.47% | 59.09% | 61.43% | |
R&D Expenses | $22.4M | $37.2M | $38.3M | $32.9M | $39.6M | |
Selling, General & Admin | $28.5M | $56.5M | $67.2M | $64.7M | $52.2M | |
Other Inc / (Exp) | -$3.3M | $413K | -$20.9M | -- | -- | |
Operating Expenses | $50.9M | $93.7M | $105.4M | $97.6M | $91.8M | |
Operating Income | $3.3M | -$13.6M | -$12.2M | $11.5M | $37.6M | |
Net Interest Expenses | $2.3M | $2.1M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$2.3M | -$15.2M | -$27.9M | $14.3M | $41.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $996K | $3.3M | -$11.5M | $116K | $3.2M | |
Net Income to Company | -$3.3M | -$18.6M | -$16.4M | $14.1M | $38.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$3.3M | -$18.6M | -$16.4M | $14.1M | $38.2M | |
Basic EPS (Cont. Ops) | -$0.07 | -$0.17 | -$0.17 | $0.16 | $0.42 | |
Diluted EPS (Cont. Ops) | -$0.07 | -$0.17 | -$0.17 | $0.15 | $0.39 | |
Weighted Average Basic Share | $49.4M | $107M | $95.6M | $90.8M | $92M | |
Weighted Average Diluted Share | $49.4M | $107M | $95.6M | $93.8M | $102.3M | |
EBITDA | $20.9M | $10.8M | $3.3M | $48.4M | $72.8M | |
EBIT | -$87K | -$13.2M | -$25.7M | $16.6M | $43.6M | |
Revenue (Reported) | $93.7M | $127.3M | $165.1M | $184.7M | $210.7M | |
Operating Income (Reported) | $3.3M | -$13.6M | -$12.2M | $11.5M | $37.6M | |
Operating Income (Adjusted) | -$87K | -$13.2M | -$25.7M | $16.6M | $43.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $339.2M | $462.2M | $614.1M | $712.5M | $806.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $150.4M | $178.3M | $236.6M | $299.1M | $323.3M | |
Gross Profit | $188.9M | $284M | $377.5M | $413.4M | $483.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $77.9M | $130.5M | $144.9M | $131.6M | $148.1M | |
Selling, General & Admin | $111M | $181.5M | $256.9M | $225.3M | $218.1M | |
Other Inc / (Exp) | -$16.4M | $319K | -$20.9M | -$18K | -- | |
Operating Expenses | $188.9M | $312M | $401.8M | $356.9M | $366.2M | |
Operating Income | -$50K | -$28M | -$24.3M | $56.5M | $117.1M | |
Net Interest Expenses | $12.4M | $3.4M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$28.8M | -$31.1M | -$36.5M | $68.9M | $124.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.2M | $3.6M | -$10.9M | $19M | $16.3M | |
Net Income to Company | -$30M | -$34.7M | -$25.6M | $49.9M | $108.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$30M | -$34.7M | -$25.6M | $49.9M | $108.6M | |
Basic EPS (Cont. Ops) | -$0.35 | -$0.32 | -$0.26 | $0.57 | $1.19 | |
Diluted EPS (Cont. Ops) | -$0.35 | -$0.32 | -$0.26 | $0.53 | $1.11 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $62.7M | $63.8M | $79.2M | $198.8M | $261.2M | |
EBIT | -$16.5M | -$27.5M | -$28M | $77.9M | $133.8M | |
Revenue (Reported) | $339.2M | $462.2M | $614.1M | $712.5M | $806.6M | |
Operating Income (Reported) | -$50K | -$28M | -$24.3M | $56.5M | $117.1M | |
Operating Income (Adjusted) | -$16.5M | -$27.5M | -$28M | $77.9M | $133.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $93.7M | $127.3M | $165.1M | $184.7M | $210.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $39.5M | $47.2M | $71.9M | $75.6M | $81.3M | |
Gross Profit | $54.1M | $80.1M | $93.3M | $109.1M | $129.4M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $22.4M | $37.2M | $38.3M | $32.9M | $39.6M | |
Selling, General & Admin | $28.5M | $56.5M | $67.2M | $64.7M | $52.2M | |
Other Inc / (Exp) | -$3.3M | $413K | -$20.9M | -- | -- | |
Operating Expenses | $50.9M | $93.7M | $105.4M | $97.6M | $91.8M | |
Operating Income | $3.3M | -$13.6M | -$12.2M | $11.5M | $37.6M | |
Net Interest Expenses | $2.3M | $2.1M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$2.3M | -$15.2M | -$27.9M | $14.3M | $41.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $996K | $3.3M | -$11.5M | $116K | $3.2M | |
Net Income to Company | -$3.3M | -$18.6M | -$16.4M | $14.1M | $38.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$3.3M | -$18.6M | -$16.4M | $14.1M | $38.2M | |
Basic EPS (Cont. Ops) | -$0.07 | -$0.17 | -$0.17 | $0.16 | $0.42 | |
Diluted EPS (Cont. Ops) | -$0.07 | -$0.17 | -$0.17 | $0.15 | $0.39 | |
Weighted Average Basic Share | $49.4M | $107M | $95.6M | $90.8M | $92M | |
Weighted Average Diluted Share | $49.4M | $107M | $95.6M | $93.8M | $102.3M | |
EBITDA | $20.9M | $10.8M | $3.3M | $48.4M | $72.8M | |
EBIT | -$87K | -$13.2M | -$25.7M | $16.6M | $43.6M | |
Revenue (Reported) | $93.7M | $127.3M | $165.1M | $184.7M | $210.7M | |
Operating Income (Reported) | $3.3M | -$13.6M | -$12.2M | $11.5M | $37.6M | |
Operating Income (Adjusted) | -$87K | -$13.2M | -$25.7M | $16.6M | $43.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $100.3M | $1.7B | $140.8M | $317.2M | $428.4M | |
Short Term Investments | -- | -- | $723.5M | $94.5M | -- | |
Accounts Receivable, Net | $28.1M | $39.6M | $53.8M | $62.2M | $72.5M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | $15.1M | $17.5M | |
Other Current Assets | $19.5M | $17.1M | $27.9M | $1.4M | $4.6M | |
Total Current Assets | $148M | $1.8B | $946M | $503M | $541.7M | |
Property Plant And Equipment | $239M | $249.6M | $426.9M | $460.6M | $620.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $2.7M | $32.2M | $315.2M | $348.3M | $348.7M | |
Other Intangibles | $34.6M | $42.9M | $118.9M | $140.2M | $117.7M | |
Other Long-Term Assets | $5.9M | $6.1M | $7.9M | $6.9M | $10.3M | |
Total Assets | $430.3M | $2.1B | $1.8B | $1.5B | $1.6B | |
Accounts Payable | $12.4M | $12.7M | $21.1M | $4M | $54.6M | |
Accrued Expenses | $27M | $31.9M | $34M | $31M | $38.2M | |
Current Portion Of Long-Term Debt | $17.5M | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | $57.4M | $86.5M | $79.3M | |
Other Current Liabilities | $15.2M | $599K | -- | -- | $3.2M | |
Total Current Liabilities | $84.8M | $58.2M | $165.5M | $192.6M | $221M | |
Long-Term Debt | $242.2M | $1.5B | $1.5B | $1.5B | $1.5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $502.3M | $1.5B | $1.8B | $1.8B | $1.8B | |
Common Stock | $1K | $2K | $2K | $2K | $2K | |
Other Common Equity Adj | -$245K | -$374K | -$2M | -$452K | -$1.5M | |
Common Equity | -$72.1M | $578.2M | $47.6M | -$313.7M | -$203M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$72.1M | $578.2M | $47.6M | -$313.7M | -$203M | |
Total Liabilities and Equity | $430.3M | $2.1B | $1.8B | $1.5B | $1.6B | |
Cash and Short Terms | $100.3M | $1.7B | $864.2M | $411.8M | $428.4M | |
Total Debt | $259.7M | $1.5B | $1.5B | $1.5B | $1.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $560.1M | $464.8M | $20.9M | $419.1M | $360.4M | |
Short Term Investments | -- | $1.1B | $591.7M | -- | -- | |
Accounts Receivable, Net | $28.9M | $42.5M | $55M | $63.9M | $76.6M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $18.3M | $14.2M | $31.1M | $32.9M | $42.2M | |
Total Current Assets | $607.3M | $1.6B | $698.6M | $515.8M | $479.2M | |
Property Plant And Equipment | $242.7M | $259.4M | $463.5M | $478.1M | $689.2M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $2.7M | $32.2M | $296.6M | $348.3M | $348.7M | |
Other Intangibles | $34.6M | $46.5M | $117.6M | $134.4M | $113.5M | |
Other Long-Term Assets | $5.9M | $6.8M | $7.3M | $7M | $10.5M | |
Total Assets | $893.3M | $2B | $1.6B | $1.5B | $1.6B | |
Accounts Payable | $15.1M | $16.3M | $11M | $4.5M | $9.4M | |
Accrued Expenses | $16.8M | $25.6M | $38.2M | $24.4M | $42.8M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | $73.1M | $81.2M | $92.9M | |
Other Current Liabilities | $767K | $15.2M | $58.9M | $73.3M | $47.6M | |
Total Current Liabilities | $46M | $62.5M | $186.2M | $189M | $198.3M | |
Long-Term Debt | -- | $1.5B | $1.5B | $1.5B | $1.5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $48.2M | $1.5B | $1.8B | $1.8B | $1.9B | |
Common Stock | $2K | $2K | $2K | $2K | $2K | |
Other Common Equity Adj | -$233K | -$2.3M | -$679K | -$591K | -$1.2M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $845.1M | $427.8M | -$217.7M | -$286.1M | -$210.7M | |
Total Liabilities and Equity | $893.3M | $2B | $1.6B | $1.5B | $1.6B | |
Cash and Short Terms | $560.1M | $1.6B | $612.6M | $419.1M | $360.4M | |
Total Debt | -- | $1.5B | $1.5B | $1.5B | $1.5B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$43.6M | -$19.5M | -$27.8M | $19.4M | $84.5M | |
Depreciation & Amoritzation | $75.6M | $88.4M | $102.2M | $117.9M | $130.1M | |
Stock-Based Compensation | $29.5M | $61.6M | $105.8M | $88.3M | $90.5M | |
Change in Accounts Receivable | -$18.5M | -$20.7M | -$26.6M | -$22.7M | -$26.7M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $58.5M | $133.1M | $195.2M | $234.9M | $282.7M | |
Capital Expenditures | $115.8M | $109.1M | $120.2M | $124.8M | $186.5M | |
Cash Acquisitions | -- | -$5M | -$305.2M | -$99M | -- | |
Cash From Investing | -$115.6M | -$113.6M | -$1.1B | $401.2M | -$94.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $229.9M | $1.5B | -- | -- | -- | |
Long-Term Debt Repaid | -$176M | -$263.4M | -- | -$2.3M | -$5.5M | |
Repurchase of Common Stock | -$1.4M | -$350M | -$600M | -$488.5M | -$59.8M | |
Other Financing Activities | $7.8M | -$3.2M | -$29.8M | -$21.6M | -$28.3M | |
Cash From Financing | $124M | $1.6B | -$610.4M | -$468.9M | -$76.4M | |
Beginning Cash (CF) | $35.9M | $102.5M | $1.7B | $151.8M | $319M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $66.9M | $1.6B | -$1.6B | $167.2M | $111.5M | |
Ending Cash (CF) | $102.5M | $1.7B | $151.8M | $319M | $430.2M | |
Levered Free Cash Flow | -$57.3M | $24M | $74.9M | $110.1M | $96.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$3.3M | -$18.6M | -$16.4M | $14.1M | $38.2M | |
Depreciation & Amoritzation | $21M | $23.9M | $28.9M | $31.9M | $29.2M | |
Stock-Based Compensation | $6.6M | $26M | $31.5M | $22.9M | $19.4M | |
Change in Accounts Receivable | -$3.7M | -$6.9M | -$5.1M | -$5.9M | -$8.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $19.8M | $30.4M | $36.2M | $66.7M | $64.1M | |
Capital Expenditures | $23.8M | $25.3M | $25.1M | $45.2M | $65M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$23.7M | -$1.1B | $108M | $46.4M | -$65M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$263.2M | -- | -- | -$1.4M | -$1.4M | |
Repurchase of Common Stock | -- | -$150M | -$265.9M | -$8.8M | -$59.1M | |
Other Financing Activities | -- | -$13.3M | -$3.9M | -$6.8M | -$8.7M | |
Cash From Financing | $463.6M | -$157.9M | -$264.2M | -$11.2M | -$67.2M | |
Beginning Cash (CF) | $102.5M | $1.7B | $151.8M | $319M | $430.2M | |
Foreign Exchange Rate Adjustment | -- | -$49K | -$29K | -$66K | $39K | |
Additions / Reductions | $459.7M | -$1.2B | -$120.1M | $101.9M | -$68.1M | |
Ending Cash (CF) | $562.3M | $466.9M | $31.7M | $420.8M | $362.2M | |
Levered Free Cash Flow | -$4M | $5.1M | $11.1M | $21.5M | -$885K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$30M | -$34.7M | -$25.6M | $49.9M | $108.6M | |
Depreciation & Amoritzation | $79.1M | $91.4M | $107.2M | $120.8M | $127.4M | |
Stock-Based Compensation | $26.7M | $80.9M | $111.4M | $79.7M | $87.1M | |
Change in Accounts Receivable | -$17M | -$23.9M | -$24.8M | -$23.4M | -$29.2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $76.9M | $143.7M | $201M | $265.4M | $280.1M | |
Capital Expenditures | $111.3M | $110.7M | $120M | $144.9M | $206.3M | |
Cash Acquisitions | -- | -$5M | -$305.2M | -$99M | -- | |
Cash From Investing | -$111.1M | -$1.2B | $80.8M | $339.6M | -$206.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$280.9M | -- | -- | -$3.6M | -$5.5M | |
Repurchase of Common Stock | -- | -$500M | -$715.9M | -$231.3M | -$110.1M | |
Other Financing Activities | -- | -$16.5M | -$20.4M | -$24.5M | -$30.3M | |
Cash From Financing | $503.2M | $971.9M | -$716.7M | -$215.9M | -$132.4M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $469M | -$95.4M | -$434.9M | $389.1M | -$58.5M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$34.4M | $33.1M | $81M | $120.5M | $73.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$3.3M | -$18.6M | -$16.4M | $14.1M | $38.2M | |
Depreciation & Amoritzation | $21M | $23.9M | $28.9M | $31.9M | $29.2M | |
Stock-Based Compensation | $6.6M | $26M | $31.5M | $22.9M | $19.4M | |
Change in Accounts Receivable | -$3.7M | -$6.9M | -$5.1M | -$5.9M | -$8.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $19.8M | $30.4M | $36.2M | $66.7M | $64.1M | |
Capital Expenditures | $23.8M | $25.3M | $25.1M | $45.2M | $65M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$23.7M | -$1.1B | $108M | $46.4M | -$65M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$263.2M | -- | -- | -$1.4M | -$1.4M | |
Repurchase of Common Stock | -- | -$150M | -$265.9M | -$8.8M | -$59.1M | |
Other Financing Activities | -- | -$13.3M | -$3.9M | -$6.8M | -$8.7M | |
Cash From Financing | $463.6M | -$157.9M | -$264.2M | -$11.2M | -$67.2M | |
Beginning Cash (CF) | $102.5M | $1.7B | $151.8M | $319M | $430.2M | |
Foreign Exchange Rate Adjustment | -- | -$49K | -$29K | -$66K | $39K | |
Additions / Reductions | $459.7M | -$1.2B | -$120.1M | $101.9M | -$68.1M | |
Ending Cash (CF) | $562.3M | $466.9M | $31.7M | $420.8M | $362.2M | |
Levered Free Cash Flow | -$4M | $5.1M | $11.1M | $21.5M | -$885K |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.